Clinical trial Recruiting at 1 site Interventional Ages 18 to 70

Magnesium sulfate added to lidocaine for trigger point injections in myofascial pain

Official title: Evaluation of the Effect of Adding Magnesium Sulfate to Lidocaine in the Treatment of Myofascial Pain Dysfunction Syndrome Using Surface Electromyography (sEMG).(Randomized Clinical Trial)

Run by Cairo University · NCT07390851 · Data updated 2026-11-12

This study will see if adding magnesium sulfate to lidocaine injections helps reduce pain and relax muscles in adults with myofascial pain dysfunction syndrome.

More Myofascial Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment28 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Giza, Giza Governorate)
StatusRecruiting
StartedNovember 26, 2025
Main results expectedNovember 26, 2026
Study endsNovember 26, 2026
Registry record updatedFebruary 5, 2026
Trial IDNCT07390851 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 with a clinical diagnosis of MPDS, active accessible trigger points, pain for at least 3 months, baseline VAS ≥ 4, and no trigger point injection in the affected area within the prior 3 months are ideal candidates.

Probably not a fit

Patients with central pain syndromes (such as fibromyalgia), cancer-related pain, allergies to lidocaine or magnesium, bleeding disorders, local infections, or recent surgery/trauma in the area are unlikely to benefit or may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a randomized trial, adults with clinically diagnosed Myofascial Pain Dysfunction Syndrome will be assigned to receive trigger point injections of either lidocaine 2% alone or lidocaine 2% combined with magnesium sulfate 10%. Injections will be given into identified active myofascial trigger points and pain during and after injection will be measured using a Visual Analog Scale (VAS). Muscle activity will be recorded with surface electromyography (sEMG) at specified time points during rest and contraction to compare muscle relaxation between groups. The study compares changes in pain scores and sEMG readings to determine whether magnesium sulfate provides additional analgesic or muscle-relaxing effects.

Why it matters

Potential benefit: If successful, the combination could provide greater pain relief and improved muscle relaxation after trigger point injections for patients with MPDS.

How similar studies have gone: Magnesium sulfate has shown mixed but sometimes promising results as an adjuvant to local anesthetics in other pain settings, but its specific use in trigger point injections for MPDS is limited and not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 70 years.
2. Clinical diagnosis of Myofascial Pain Dysfunction Syndrome (MPDS).
3. Presence of active myofascial trigger points in accessible muscles (e.g., masseter, temporalis, upper trapezius).
4. Pain duration ≥ 3 months.
5. Pain intensity ≥ 4 on the Visual Analog Scale (VAS).
6. Noprior trigger point injection in the affected area within the past 3 months.
7. Ability and willingness to provide informed consent.
8. Compliance with study visits and procedures

Exclusion Criteria:

1. Known allergy or hypersensitivity to Lidocaine, Magnesium Sulfate, or related agents.
2. Current use of anticoagulants or history of bleeding disorders.
3. Systemic or local infection at or near the injection site.
4. History of fibromyalgia, central pain syndromes, or cancer-related pain.
5. Major psychiatric illnesses (e.g., schizophrenia, severe depression).
6. Recent surgery or trauma to the head, neck, or upper back (\<6 months).
7. Use of analgesics (NSAIDs, opioids) within 5 days before intervention.
8. Severe systemic diseases:- Uncontrolled diabetes mellitus- Liver or kidney failure- Severe cardiovascular conditions.

Where it's running

  • Faculty of oral and dental medicine, cairo university
    Giza, Giza Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.